Search Results

240 results for icgn

Take Profits If You Own Ocugen Stock, but Now’s Not the Time to Buy

As Ocugen has a long way to go to get approval from the FDA and commercialize Covaxine, OCGN stock will not likely to reach new…

Ocugen Is a Crisis Trade That Just Might Pan Out

OCGN stock is risky yet the underlying science behind its Covid-19 vaccine combined with a messy situation in the U.S. bodes well.

Read the Label Carefully Before Gambling on Ocugen Stock

OCGN stock has tempted many speculators recently with its high-flying acrobatics. But you’ll want to read the label on Ocugen very carefully before even thinking…

Ocugen Needs Too Much Time and Too Much Cash

OCGN stock has held up despite the failure of what was its flagship drug. The remaining pipeline simply isn’t strong enough for investors to risk…

OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today

OCGN stock is pulling back after a muted earnings report this morning, as Ocugen makes a big bet on Covaxin for kids.

OCGN Stock Soars 30% as WHO Kicks Off COVAXIN Review

OCGN stock is racing higher as the WHO kicks off its review of partner Bharat Biotech’s COVAXIN vaccine. Here’s what to know.

OCGN Stock: 2 Big Reasons Ocugen Shares Are Soaring Today

OCGN stock is on the move today thanks to two big headlines about its Covid-19 vaccine plans. Here’s what to know.

Ocugen Will Have Value If Its Covid Vaccine Can Get Approved

OCGN stock could be at a full value today given its revenue prospects but could still rise if its Covaxin vaccine gains approval outside India.

Ocugen Stock Just Needs a Catalyst to Break Free

OCGN stock holders should be patient as the World Health Organization’s potential approval of an important vaccine could happen soon.

Ocugen Stock Is a Speculative Covid-19 Vaccine Bet

OCGN stock is a speculative bet. FDA approval of Covaxin would boost the shares. However, the firm’s revenue potential is limited.

Don’t Get Suckered Into Ocugen Stock

OCGN stock has gone crazy amid a partnership to develop a Covid-19 vaccine. The problem is there’s little evidence it will actually work.

The Excitement Around Ocugen Is Irrational

OCGN stock surged on news of a coronavirus vaccine, but its fundamentals do not support its stock price, making it another speculative bet.

Ocugen Stock Is Not One to Trust With Nest Egg Funds

There is too much riding on hope for OCGN stock. It is OK to trade it but fundamental investments are too risky for most.

Ocugen Likely Can’t Get a Boost From the FDA Until 2023

It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.

Ocugen Investors Are Missing the Obvious Signs of Failure

Initially, the stupendous rise of OCGN stock may give you the case of the FOMOs. But don’t let that emotions guide you as Ocugen is…

Iconic Implosions: 3 Blue-Chip Stocks to Bail On Before It’s Too Late

Beware of these iconic yet overvalued blue-chip stocks that are sinking on bad news and negative media headlines.

OCGN Stock Alert: What Is Going on With Red-Hot Ocugen Today?

Investors are in a speculative frenzy around COVAXIN ahead of a WHO meeting tomorrow. OCGN stock is rallying as a result.

Get Rid of Ocugen Stock While You Can as the Bad News Piles Up

After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.

Make Sure You See Ocugen Stock With Clear Eyes

OCGN stock is a hot trade at this point in 2021. But it’s important for investors to see the company’s outlook clearly.

OCGN Stock: 3 Big Reasons Ocugen Is Rocketing Higher Today

Investors in OCGN stock have a number of catalysts to point to today as reasons to hold onto this outperforming stock.

OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial

OCGN stock fell into the red despite Ocugen’s success in advancing a regenerative cell therapy product evaluation.

Consider Buying Range-Bound Apple Stock Before It Reaches New Highs

Although Apple is one of the consumer technology icons, AAPL stock is likely to be range-bound in the coming weeks.

Google Internet Service Should Scare AT&T and Verizon

Google says it’s not looking to become a threat to wireless icons AT&T and Verizon, but that’s tough to believe.

Thinking Beyond EVs Will Boost Ford Motor Company Stock

It’s not a reason in and of itself to buy Ford stock, but the Detroit icon is finally thinking proactively about the future.

8 – 10 of 240 results